Track Pharmicell , Ltd.'s total liabilities ($44B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Pharmicell , Ltd. (005690.KS) currently reports a total liabilities of $44B as of September 2026. That compares with $20B in the prior-year period — up 123.8% year over year. Use the charts on this page to explore Pharmicell , Ltd.'s total liabilities history and peer comparisons.
Pharmicell , Ltd.'s total liabilities increased from $20B to $44B — a 123.8% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Pharmicell , Ltd. reported $44B in total liabilities as of September 2026. That compares with $20B in the prior-year period — up 123.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $44B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pharmicell , Ltd., and consider following 005690.KS for alerts when major investors trade the stock.
Pharmicell , Ltd. is classified in the Healthcare sector. On total liabilities, it currently shows $44B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 005690.KS with unrelated industries.